Efficient Ex Vivo Expansion of ?d T-Cells from AML Patients Requires Elimination of Circulating Leukemic Blasts (2020)
Attributed to:
Development of enhanced gene specific technology for the isolation of proteins binding at a single locus in vivo.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.36959/486/327
Publication URI: http://dx.doi.org/10.36959/486/327
Type: Journal Article/Review
Parent Publication: Advances in Leukemia Research and Treatment
Issue: 1